Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
05.08.24
/
50%
€432.30
Target price
05.08.25
€464.36
Performance (%)
-0.32%
Price
16:49
€430.90
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 05.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.963% | -0.963% |
iShares Core DAX® | 1.510% | 2.268% |
iShares Nasdaq 100 | -0.271% | -1.533% |
iShares Nikkei 225® | -0.108% | 0.411% |
iShares S&P 500 | 0.479% | 0.563% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $505.00 to $510.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.30
01.02.24
01.02.24
€404.41
01.02.25
01.02.25
7.64%
16:49
16:49